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Abstract
Background: Severe maternal conditions have increasingly been used as alternative measurements of the quality
of maternal care and as alternative strategies to reduce maternal mortality. We aimed to study severe maternal
morbidity and maternal near miss among women in two tertiary hospitals in Kota Bharu, Kelantan, Malaysia.
Methods: A cross-sectional study with record review was conducted in 2014. Severe maternal morbidity and
maternal near miss were classified using the new World Health Organization criteria. Health indicators for obstetric
care were calculated and descriptive analyses were performed using SPSS version 22.0.
Results: In total, 21,579 live births, 395 women with severe maternal morbidity, 47 women with maternal near miss
and two maternal deaths were analysed. The severe maternal morbidity incidence ratio was 18.3 per 1000 live
births and the maternal near miss incidence ratio was 2.2 per 1000 live births. The maternal near miss mortality
ratio was 23.5 and the mortality index was 4.1 %. The process indicators for essential interventions were almost
100.0 %. Haemorrhagic disorders were the most common event for severe maternal morbidity (68.6 %) and
maternal near miss (80.9 %) and management-based criteria accounted for 85.1 %.
Conclusions: Comprehensive emergency care and intensive care as well as overall improvements in the quality of
maternal health care need to be achieved to substantial reduce maternal death.
Keywords: Severe maternal morbidity, Maternal near miss, Maternal deaths, Obstetric complications, WHO near
miss approach
Background
Investing in maternal health is considered one of the
crucial elements in the development agenda of countries.
Of the eight Millennium Development Goals (MDGs),
goal five includes 'improving maternal health'; this goal
consists of two targets, one of which is to reduce mater-
nal mortality by three-quarters between 1990 and 2015.
In developing countries, the unacceptably high maternal
death overshadows maternal morbidity. Because mater-
nal morbidities occur more frequently than maternal
deaths, maternal near miss was suggested as a more use-
ful indicator for the evaluation and improvement of
maternal health services than the maternal mortality ra-
tio (MMR) [1].
In Malaysia, the national MMR have shown an impres-
sive decline of 94 % from 530 per 100,000 live births in
1950 to 28 per 100,000 live births in 2009. This decline
was largely due to the introduction of competency-based
training and placement of midwives in rural areas, in
addition to advances in medicine and technology, im-
provements in the health care delivery system and imple-
mentation of a risk approach strategy and confidential
enquiry into maternal deaths (CEMD). In spite of these
improvements, the MMR has remained plateaued at ap-
proximately 28 to 30 per 100,000 live births since the year
2000 [2].
The World Health Organization (WHO) Working Group
on Maternal Mortality Morbidity Classifications has re-
cently developed a standard definition and internationally
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accepted identification criteria for very severe and severe
maternal morbidity cases. Hence, maternal near miss or
very severe maternal morbidity, is defined as 'a woman who
nearly died but survived a complication that occurred dur-
ing pregnancy, childbirth or within 42 days of termination
of pregnancy'. Additionally, severe maternal morbidity
refers to ‘potentially life-threatening conditions during
pregnancy, childbirth or after termination of pregnancy
from which maternal near miss cases would emerge'. The
identification of maternal near miss cases is based on the
presence of 25 criteria regarding organ and system dysfunc-
tion (cardiovascular, respiratory, renal, coagulation, hepatic,
neurologic and uterine) via clinical-, laboratory- and
management-based parameters. In contrast, the identifica-
tion of severe maternal morbidity is based on a list of po-
tentially life-threatening conditions from which maternal
near miss cases would emerge [3, 4].
Reporting the magnitude of severe and very severe
maternal morbidities is the first important step in meas-
uring the quality of a maternity system. This reporting
may act as a complement to CEMD or as an alternative
strategy to reduce maternal mortality. Second, identify-
ing the severe maternal morbidities or potentially life-
threatening conditions from which maternal near miss
cases would emerge based on the recently developed
standard definition and internationally accepted identifi-
cation criteria by the WHO [3] allows for valid compari-
sons across countries and regions. This standardization
is important because existing studies showed variation in
the definition and criteria used.
This study aims to study severe maternal morbidity
and maternal near miss among women as proposed by
the WHO near miss approach and related indicators in
tertiary hospitals in Kelantan, Malaysia. To our know-
ledge, this study is the first in Malaysia to assess mater-
nal morbidities using the working guidelines.
Methods
In a cross-sectional study conducted in Raja Perempuan
Zainab II Hospital and Universiti Sains Malaysia Hos-
pital, Kelantan, data from postpartum women were
obtained throughout the 1 year period of 2014. Raja
Perempuan Zainab II Hospital and Universiti Sains
Malaysia Hospital are the two referral and tertiary hospi-
tals with approximately 14,000 and 7000 deliveries per
year, respectively [5]. The study population includes all
postpartum women regardless of age. Women who de-
veloped complications beyond 42 days of termination of
pregnancy were excluded. Data regarding the total num-
ber of live births and maternal deaths occurring in the
facilities during the study period were also collected.
Sample size calculation to determine the prevalence of
severe maternal morbidity and maternal near miss was
performed using a single proportion formula [6]. The
17.46 % [7] and 2.93 % [8] prevalence, respectively, of se-
vere maternal morbidity and maternal near miss based
on the WHO criteria were taken because they yielded
the largest sample size. For severe maternal morbidity,
taking the precision of 0.01 with 95 % confidence, the
minimum required sample size was 5537. After consid-
ering a non-response rate of 20 %, the calculated sample
size was 6644 postpartum women. For maternal near
miss, taking the precision of 0.01 with 95 % confidence,
the minimum required sample size was 1093. After con-
sidering a non-response rate of 20 %, the calculated sam-
ple size was 1312 postpartum women. Therefore, data
from a minimum of 6644 women were needed.
However, in this context, obtaining the frequency of
severe maternal morbidity and maternal near miss cases
for a 1 year period is far more important than estimating
the sampling frame for determining prevalence. This
overall picture produces a more valid comparison be-
tween the severe maternal morbidity ratio, maternal near
miss ratio and maternal mortality ratio. Therefore, an
approximately 20,000 women at the two facilities in
2014 formed the sampling frame for this study.
The WHO near miss approach was utilized to ob-
tained information regarding morbidity criteria for
severe maternal morbidity (haemorrhagic disorders,
hypertensive disorders, other systemic disorders and se-
vere management indicators) and organ dysfunction cri-
teria for maternal near miss (vital organ dysfunction or
failure, for example, circulatory, respiratory, cardiac,
renal, hepatic, central nervous, metabolic and haemato-
logical). In addition, care based on essential interven-
tions and its process indicators, i.e., prevention and
treatment of postpartum haemorrhage, treatment of
eclampsia and prevention and treatment of infection or
sepsis, were assessed [4]. Hospital- and home-based
medical records were reviewed to retrieve patient infor-
mation and severe maternal morbidity and maternal
near miss criteria. The extracted information included
sociodemographic characteristics, current obstetric his-
tory, clinical parameters, past obstetric history, medical
and gynaecological history, foetal outcome and health
care provision.
Severe maternal morbidity and maternal near miss
cases were identified throughout the 1 year period at
both facilities. A research assistant trained in nursing
reviewed the admission registers and medical records in
delivery rooms and obstetrics and gynaecology wards
daily. Information regarding women with severe mater-
nal morbidity as identified by the life-threatening condi-
tions was obtained. Among these women, maternal near
miss cases were identified by the presence of organ sys-
tem dysfunction. To decrease the risk of selection bias
and to minimize the number of missed cases, all preg-
nancies and deliveries with any medical problem, not
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only potentially life-threatening conditions, were reviewed.
The medical staffs were also asked regarding any cases ful-
filling the criteria. The researcher made the final choice
for inclusion.
The data were entered and analysed using IBM SPSS
Statistics version 22.0 (SPSS Inc., 2013). The data were
checked and filtered before analysis. Descriptive analysis
was used to determine the prevalence of severe maternal
morbidity and maternal near miss based on the denom-
inator of live births. Background characteristics of the
women, morbidity and organ dysfunction criteria and
process indicators were explored.
This study protocol was approved and the access to
patient medical records were issued by the Human
Research Ethics Committee, Universiti Sains Malaysia
(USM/PPSP®/2012/JKP-62[62.3(4)]) and Medical Re-
search Ethics Committee, Ministry of Health (KKM/
NIHSEC/800-2/2/2/Jld 2 P13-215). The data were ob-
tained from the medical records; therefore, this part
of the study was exempt from informed consent pro-
cedures. The confidentiality of the data regarding the
participating women was preserved.
Results
During the 1 year data collection period, 21,756 deliver-
ies, 21,579 live births, 395 women with severe maternal
morbidity, 47 women with maternal near miss and two
maternal deaths were recorded. On average, seven to
eight women with severe maternal morbidity were iden-
tified per week. In total, 308 (78.0 %) women with severe
maternal morbidity and 42 (89.4 %) women with mater-
nal near miss delivered at Raja Perempuan Zainab II
Hospital. Two maternal deaths were reported.
The severe maternal morbidity incidence ratio was
18.3 per 1000 live births and the maternal near miss in-
cidence ratio was 2.2 per 1000 live births. These ratios
were used to calculate the prevalence values of severe
maternal morbidity and maternal near miss of 1.83 and
0.22 %, respectively. The sociodemographic and medical
characteristics of women with severe maternal morbidity
(n = 395) and maternal near miss (n = 47) are shown in
Tables 1 and 2, respectively.
Morbidity criteria
Table 3 covers the morbidities justifying the inclusion of
the affected women in the study. Scrutiny of the data in
this table will allow identification of the pattern of
morbidities among those women who survived severe
pregnancy-related complications. Among women with
severe maternal morbidity, haemorrhagic disorders (68.6 %)
were the most common criteria for morbidity followed by
severe management indicators (54.4 %) and hypertensive
disorders (33.4 %). In total, 48.9 and 17.0 % of the cases re-
quired blood transfusion and intensive care unit admission,
respectively. Among the 395 cases, 183 (46.3 %) women de-
veloped severe morbidity conditions at arrival or within
12 h of arrival and 166 (42.0 %) developed severe morbidity
conditions 12 h after arrival; of these women, the number
of referred cases were 125 (68.3 %) within 12 h of arrival
and 115 (69.3 %) 12 h after arrival.
Among women with maternal near miss, severe man-
agement indicators (91.5 %) were the most common cri-
teria for morbidity followed by haemorrhagic disorders
(80.9 %) and other systemic disorders (38.3 %). In total,
83.0 and 72.3 % of the cases required blood transfusion
and ICU admission, respectively. Among the 47 cases,
Table 1 Sociodemographic characteristics of women with
severe maternal morbidity and maternal near miss
Variables SMM (n = 395) MNM (n = 47)
n (%) n (%)
Age (years) 31.5 (6.35)a 33.2 (6.03)a
Age
< 35 years 265 (67.1) 27 (57.4)
≥ 35 years 130 (32.9) 20 (42.6)
Age at marriage (years) 23.2 (4.47)a,b 24.4 (5.57)a,h
Duration of marriage (years) 8.4 (6.98)a,b 7 (15.0)d,h
Household income (MR/monthly) 1800 (2000.0)c,d 2350 (3525.0)d,e
Race
Malay 386 (97.7) 46 (97.9)
Others 9 (2.3) 1 (2.1)
Level of education
Nil and primary 21 (5.3) 6 (12.8)
Secondary 239 (60.5) 22 (46.8)
Tertiary 135 (34.2) 19 (40.4)
Occupation
Unemployed 210 (53.2) 19 (40.4)
Self-employed 31 (7.8) 4 (8.5)
Support group 99 (25.1) 13 (27.7)
Professional group 55 (13.9) 11 (23.4)
Marital status
Married 390 (98.7) 46 (97.9)
Single 5 (1.3) 1 (2.1)
Husband occupation
Unemployed 7 (1.8)b 1 (2.2)e
Self-employed 150 (38.6) 19 (41.3)
Non-professional group 188 (48.3) 18 (39.1)
Professional group 44 (11.3) 8 (17.4)
SMM severe maternal morbidity, MNM maternal near miss
amean (standard deviation)
bn = 389. Six women (four singles and two non-Malaysians) have no related
marital information
cn = 378
dmedian (interquartile range). Skewed to the right
en = 46. One woman unmarried
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26 (55.3 %) women developed near miss conditions at
arrival or within 12 h of arrival and 15 (31.9 %) devel-
oped the conditions 12 h after arrival; of these women,
the number of referred cases were 16 (61.5 %) within
12 h of arrival and eight (53.3 %) 12 h after arrival.
Three cases of uterine rupture were reported: one with
an unscarred uterus and two with a scarred uterus.
The overall ICU admission rate was 0.3 % (67/21,579)
and the admission rate for women with maternal near
miss was 72.3 %. Haemorrhagic disorders constituted
78.9 % (abruptio placenta and ruptured uterus, 100.0 %;
postpartum haemorrhage, 80.8 %; abnormal placental in-
vasion, 80.0 %; ectopic pregnancy, 50.0 %) of all maternal
near miss admissions to the ICU. In contrast, hyperten-
sive disorders constituted 50.0 % (severe hypertension,
100.0 %; eclampsia , 50.0 %; severe pre-eclampsia,
42.9 %) and other systemic disorders constituted 72.2 %
(shock, 100.0 %; thrombocytopenia, 76.9 %; seizures,
50.0 %). For hysterectomy, 17 of 19 cases (89.5 %). For
Table 2 Medical characteristics of women with severe maternal
morbidity and maternal near miss
Variables SMM (n = 395) MNM (n = 47)
n (%) n (%)
Current obstetric history
Parity 2 (3.0)b 3.0 (3.0)b
Booking
Early (≤ 12 weeks) 196 (53.4)c 21 (48.8)d
Late (> 12 weeks) 171 (46.6) 22 (51.2)
Antenatal care visits
Optimum (≥8 visits) 320 (87.2)c 37 (86.0)d
Suboptimum (<7 visits) 47 (12.8) 6 (14.0)
Hospital stay (day) 4 (2.0)b 7 (3.0)b
Clinical parameters
Body mass index at booking (kg/m2)
Normal (18.50–24.99) 118 (32.2)c 18 (41.9)d
Underweight (≤18.49) 24 (6.5) 3 (7.0)
Overweight (25.00–29.99) 111 (30.2) 8 (18.6)
Obese (≥30.00) 114 (31.1) 14 (32.6)
Systolic blood pressure (mmHg) 134.1 (22.47)a 133.9 (23.70)a
Diastolic blood pressure (mmHg) 81.0 (13.84)a 79.2 (14.16)a
Hemoglobin level (g/dl) 11.4 (1.16)a 11.1 (1.29)a
Past obstetric history
History of previous caesarean delivery
Absent 306 (77.5) 30 (63.8)
Present 89 (22.5) 17 (36.2)
History of pregnancy complications
Absent 306 (77.5) 31 (66.0)
Present 89 (22.5) 16 (34.0)
History of previous abortion
Absent 310 (78.5) 35 (74.5)
Present 85 (21.5) 12 (25.5)
Medical history
Comorbidity
Absent 346 (87.6) 38 (80.9)
Present 49 (12.4) 9 (19.1)
SMM severe maternal morbidity, MNM maternal near miss
amean (standard deviation)
bmedian (interquartile range). Skewed to the right
cn = 367. 28 women were with early pregnancy had no antenatal care
follow up
dn = 43. Four women were with early pregnancy had no antenatal care
follow up
Table 3 Morbidity conditions of women with severe maternal
morbidity and maternal near miss
Morbidity criteria SMM (n = 395) MNM (n = 47)
n (%) n (%)
Haemorrhagic disorders 271 (68.6) 38 (80.9)
Abruptio placenta 28 (7.1) 3 (6.4)
Placenta accreta/increta/percreta 13 (3.3) 10 (21.3)
Ectopic pregnancy 31 (7.8) 4 (8.5)
Postpartum haemorrhage 210 (53.2) 26 (55.3)
Ruptured uterus 3 (0.8) 2 (4.3)
Hypertensive disorders 132 (33.4) 10 (21.3)
Severe pre-eclampsia 103 (26.1) 7 (14.9)
Eclampsia 22 (5.6) 2 (4.3)
Severe hypertension 11 (2.8) 1 (2.1)
Hypertensive encephalopathy 0 (0) 0 (0)
HELLP syndrome 16 (4.1) 6 (12.8)
Other systemic disorders 56 (14.2) 18 (38.3)
Endometritis 0 (0) 0 (0)
Pulmonary oedema 10 (2.5) 3 (6.4)
Seizures 19 (4.8) 2 (4.3)
Sepsis 2 (0.5) 0 (0)
Shock 9 (2.3) 6 (12.8)
Thrombocytopenia 28 (7.1) 13 (27.7)
Thyroid crisis 0 (0) 0 (0)
Severe management indicators 215 (54.4) 43 (91.5)
Blood transfusion 193 (48.9) 39 (83.0)
Central venous access 2 (0.5) 1 (2.1)
Hysterectomy 19 (4.8) 19 (40.4)
Intensive care unit admission 67 (17.0) 34 (72.3)
Prolonged hospital stay 6 (1.5) 3 (6.4)
Intubation not related to anesthesia 14 (3.5) 9 (19.1)
Returned to operation room 7 (1.8) 7 (14.9)
Laparotomy 22 (5.6) 11 (23.4)
SMM severe maternal morbidity, MNM maternal near miss
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hysterectomy, 17 of 19 cases (89.5 %) underwent caesar-
ean section (14 emergency and three elective caesarean
section) and 12 (63.2 %) had previous caesarean section.
Table 4 complements the information in Table 3 re-
garding the underlying causes of severe maternal mor-
bidity and maternal near miss. Previous caesarean
section contributed to most cases of severe maternal
morbidity (22.5 %) and maternal near miss (36.2 %). An-
aemia was a contributing factor in 17.2 % of severe ma-
ternal morbidity cases and in 27.7 % of maternal near
miss cases (Table 4).
Organ dysfunction criteria
Maternal near miss conditions identified according to
organ system dysfunctions are shown in Table 5. The
most common organ dysfunctions reported among ma-
ternal nearmiss cases were coagulation/haematologic
dysfunction (74.5 %) followed by uterine (40.4 %) and
cardiovascular (34.0 %) dysfunctions. Half (n = 25,
53.2 %) of the women with maternal near miss had one
organ dysfunction; 12 (25.5 %) had two organ dysfunc-
tions, eight (17.0 %) had three organ dysfunctions and
two (4.3 %) had four organ dysfunctions.
Management-based criteria (85.1 %) were the most
common criteria for maternal near miss followed by
laboratory-based (40.4 %) and clinical (14.9 %) criteria.
In total, 61.7 and 40.4 % of the cases required blood trans-
fusion of ≥ 5 units of red blood cells and hysterectomy due
to infection or haemorrhage, respectively. Severe hypoper-
fusion and severe acute thrombocytopenia were the most
common laboratory findings. Most women presented with
shock, unconsciousness and hypo- or hypertachypnoea on
clinical examination (Table 5).
End of pregnancy and pregnancy outcome
Table 6 shows the end of pregnancy and pregnancy out-
come. One case presented at the emergency department
with supra-pubic pain and was diagnosed as intra-
abdominal bleeding following which exploratory laparot-
omy was performed. Placenta percreta was observed in-
vading the urinary bladder; therefore, total hysterectomy
and bladder repair were performed.
Table 4 Underlying causes of severe maternal morbidity and
maternal near miss
Underlying causes SMM (n = 395) MNM (n = 47)
n (%) n (%)
Anaemia 68 (17.2) 13 (27.7)
Previous caesarean section 89 (22.5) 17 (36.2)
Prolonged/obstructed labour 11 (2.8) 2 (4.3)
SMM severe maternal morbidity, MNM maternal near miss
Table 5 Maternal near miss conditions according to organ
system dysfunctions
Organ dysfunction criteria MNM
(n = 47)
n (%)
Clinical criteria 7 (14.9)
Acute cyanosisb 0 (0)
Gaspingb 0 (0)
Respiratory rate >40 or <6/minb 1 (2.1)
Shock (SBP < 90 mmHg for >60/min and PR≥ 120/min)a 4 (8.5)
Oliguria (urine output < 30 ml/h for 4 h or < 400 ml/24 h)c 0 (0)
Clotting failured 0 (0)
Loss of consciousness lasting ≥ 12 hf 0 (0)
Loss of consciousness and absence of PR/HRf 1 (2.1)
Stroke ≥ 24hf 0 (0)
Uncontrollable fitf 0 (0)
Jaundice in the presence of pre-eclampsiae 0 (0)
Laboratory-based criteria 19 (40.4)
Severe hypoxaemia (oxygen saturation < 90 % for ≥ 60 min)b 1 (2.1)
Severe hypoxaemia (PaO2/FiO2 < 200 mmHg)
b 0 (0)
Severe acidosis (pH < 7.1)a 3 (6.4)
Severe hypoperfusion (lactate > 5 mmol/l)a 10 (21.3)
Severe acute azotemia (creatinine ≥ 300 mmol/L or 3.5 mg/dl)e 0 (0)
Severe acute thrombocytopenia (< 50,000 platelets)d 9 (19.1)
Severe acute hyperbilirubinemia (bilirubin >100 mmol/L
or > 6.0 mg/dl)d
0 (0)
Loss of consciousness and presence glucose
and ketoacids in urinef
0 (0)
Management-based criteria 40 (85.1)
Used of continous vasoactive druga 7 (14.9)
Intubation and ventilation≥ 60 min not related to anesthesiab 6 (12.8)
Hysterectomy following infection or hemorrhageg 19 (40.4)
Dialysis for acute renal failurec 0 (0)
Transfusion of ≥ 5 units red celld 29 (61.7)
Cardio-pulmonary resuscitationa 2 (4.3)
Organ dysfunction for the above conditions 47 (100.0)
Cardiovascular dysfunction 16 (34.0)
Respiratory dysfunction 8 (17.0)
Renal dysfunction 0 (0)
Coagulation/hematologic dysfunction 35 (74.5)
Hepatic dysfunction 1 (2.1)
Neurologic dysfunction 2 (4.3)
Uterine dysfunction 19 (40.4)
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In total, 24 cases of fresh stillbirths and 153 cases of
macerated stillbirths were reported at these two hospi-
tals (n = 177). Abruptio placenta was the primary cause
of death for the fresh stillbirths (five abruptio placenta,
one sepsis) and macerated stillbirths (two abruptio pla-
centa, one not known). Three of five fresh stillbirth
abruptio placental cases and one of two macerated
stillbirth abruptio placental cases were preterm. Early
neonatal deaths were due to abruptio placenta (term
deliveries) (n = 2) and foetal distress secondary to pro-
longed second stage labour (n = 2).
Standard procedures and process indicators
Table 7 shows the process indicators related to specific
conditions. For each condition, the target population
was identified and the proportion of that target popula-
tion receiving the recommended evidence-based inter-
vention was examined. Higher proportions of women
receiving appropriate interventions indicate better qual-
ity of care. The expected proportion of women receiving
oxytocin for prevention and treatment of postpartum
haemorrhage was almost 100.0 %. Two cases did not
receive oxytocin. The first case was woman with pre-
eclampsia who was found to have placenta accreta
during emergency caesarean section; hysterectomy was
performed. In the second case, emergency caesarean sec-
tion was performed because of secondary arrest of
labour. The patient developed severe pre-eclampsia fol-
lowing the operation. Instead of oxytocin, intramuscular
haemabate was administered.
Discussion
Descriptively, women aged less than 35 years old, without
history of previous caesarean sections or past pregnancy
complications constituted higher proportions of severe ma-
ternal morbidity and maternal near miss cases. Different
studies have reported the magnitude of severe maternal mor-
bidity or maternal near miss as incidence or prevalence.
However, incidence, referring to new cases, may not differ
from all cases reported during the study period, i.e., preva-
lence, as both were directly related to the complications that
occur in the index of pregnancy, labour or puerperium. The
various measurements make interpreting and comparing the
cases inaccurate [9]. Therefore, to harmonize the measure-
ments, prevalence was used to report the findings in this
study.
Severe maternal morbidity
Severe maternal morbidity includes a broader category
of women who suffered complications related to preg-
nancy, delivery and puerperium that were not necessarily
associated with critical illness such as blood transfusion.
The WHO criteria not only consider clinical disorders
(haemorrhagic, hypertensive and other systemic disorders)
but also severe management indicators to indicate the se-
verity and to enhance the identification of severe maternal
morbidity [3]. In this study, approximately 2 % (18.3 per
1000 live births) of the 21,756 study population had se-
vere maternal morbidity, which is comparable with the
proportions recently reported elsewhere (0.8 to 17.5 %)
[7, 8, 10–15]. The primary causes of severe maternal





n (%) n (%)
End of pregnancy
Mode of delivery
Spontaneous vaginal delivery 64 (16.2) 6 (12.8)
Assisted vaginal delivery 13 (3.3) 1 (2.1)
Elective caesarean section 39 (9.9) 5 (10.6)
Emergency caesarean section 247 (62.5) 30 (63.8)
Laparotomy - ectopic pregnancy 12 (3.0) 3 (6.4)
Laparoscopy - ectopic pregnancy 19 (4.8) 1 (2.1)
Laparotomy - intra-abdominal bleeding 1 (0.3) 1 (2.1)
Term delivery
Yes 262 (66.3) 28 (59.6)
No 133 (33.7) 19 (40.4)
Pregnancy outcome
Foetal outcome
Alive 350 (88.6) 38 (80.9)
Dead 45 (11.4) 9 (19.1)
Birth weight (kg) 2.8 (0.89)a,b 2.7 (0.91)a,c
Sex of baby
Boy 183 (50.4)b 22 (52.4)c
Girl 179 (49.3) 19 (45.2)





n (%) n (%)
If alive
Healthy 186 (53.1) 14 (36.8)
Admitted to neonatal ICU 168 (46.9) 24 (63.2)
SMM (n = 45) MNM (n = 9)
n (%) n (%)
If dead
< 22 weeks gestation 32 (71.1) 5 (55.6)
Fresh stillbirth 6 (13.3) 2 (22.2)
Macerated stillbirth 3 (6.7) 2 (22.2)
Early neonatal death 4 (8.9) 0 (0.0)
SMM severe maternal morbidity, MNM maternal near miss
amean (standard deviation)
bn = 363. 32 women were at less than 22 weeks gestation
cn = 42. Five women were at less than 22 weeks gestation
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morbidity were postpartum haemorrhage (53.2 %) and se-
vere pre-eclampsia (26.1 %). Blood transfusion and ICU
admission criteria represented 48.9 and 17.0 %, respect-
ively, of women with severe maternal morbidity in this
study.
Maternal near miss
The WHO has proposed 25 criteria based on the pres-
ence of organ and system dysfunctions (cardiovascular,
respiratory, renal, coagulation, hepatic, neurologic and
uterine dysfunctions) via clinical, laboratory- and
management-based parameters for identification of ma-
ternal near miss [3]. Even using similar proposed cri-
teria, the studies published to date have reported
considerable differences in the proportions of maternal
near miss. Most studies have reported a maternal near
miss prevalence ranging from 0.4 to 3.3 % [7, 8, 10–21].
Only one study in India reported an extremely high pro-
portion of maternal near miss of 12.0 % based on a
retrospective record review [22]. One large study, WHO
Multicountry Survey on Maternal and Newborn Health
(WHOMCS) reported the prevalence of maternal near
miss of 0.8 % among 314,623 women attending 357
health facilities in 29 countries in Africa, Asia, Latin
America and the Middle East (2538 maternal near miss
and 486 maternal deaths) [23]. Twelve countries were
involved in Asia, excluding Malaysia. Another recently
published study in Nigeria also reported a prevalence
that was within the reported range (1.6 %) [24].
The maternal near miss incidence ratio found in this
study was 2.2 per 1000 live births (0.2 %) and was slightly
low compared to other studies. As per the WHO criteria
for maternal near miss, shock (8.5 %), severe hypoperfusion
with lactate >5 mmol/L (21.3 %) and transfusion of five or
more units of red blood cells (61.7 %) were the most com-
mon clinical, laboratory- and management-based parame-
ters, respectively. Management-based parameters were the
most frequently associated criteria for near miss (85.1 %)
followed by laboratory-based criteria (40.4 %). This finding
strengthens the specificity of management-based criteria in
detecting severe obstetric cases for maternal near miss [25].
Postpartum haemorrhage, abnormal placental invasion and
severe pre-eclampsia were the leading causes of maternal
near miss (55.3, 21.3 and 14.9 %, respectively).
Considering the differences in healthcare systems and
populations, the slightly lower prevalence of maternal near
miss was justified. First, in this study, the women screened
for organ and system dysfunction criteria for maternal
near miss were from a pool of women initially classified
with severe maternal morbidity. Although a slightly lower
prevalence of maternal near miss was identified, the
prevalence of severe maternal morbidity was within the
reported range. Second, the data collection allowed clarifi-
cation of doubts regarding the records obtained from the
health personnel who took care of the women. This find-
ing indicates that the data were real and unlikely due to
underreporting. Steps were taken to ensure the data qual-
ity including pre-entry checking for completeness and
double-checking medical records for unclear cases.
Third, ectopic pregnancy, which has a different
aetiological pattern for maternal morbidity, accounted for
approximately 8 % of maternal near miss cases similarly
reported elsewhere [16, 21]. This figure is lower than that
found in other studies (approximately 12 %) with high ma-
ternal near miss prevalence [13, 24]. Studies including a
high number of early pregnancy losses in the numerator
and using deliveries or live births as the denominator
would inflate the prevalence of maternal near miss [26].
Maternal death
Maternal deaths are tragic events in obstetrics; however,
severe maternal morbidity was estimated to be 100 times
more common than death [27]. Our study found that se-
vere maternal morbidity was almost 200 times more
common than death, with almost 400 episodes affecting
approximately 22,000 women in these two tertiary cen-
tres. Maternal death indeed constitutes the most obvious
Table 7 Process indicators
Process indicator SMM MNM
Target population n (%) Target population n (%)
Prevention of postpartum haemorrhagea 363 361 (99.4) 42 41 (97.6)
Treatment of severe postpartum haemorrhageb 210 208 (99.0) 26 25 96.2)
Anticonvulsants for eclampsiac 22 22 (100.0) 2 2 (100.0)
Prevention of severe systemic infections or sepsisd 286 282 (98.6) 35 35 (100.0)
Treatment of severe infections and sepsise 2 2 (100.0) 0
SMM severe maternal morbidity, MNM maternal near miss
aThe number of women who received a single dose of oxytocin for the prevention of postpartum haemorrhage divided by the number of all women giving birth
bThe number of women with postpartum haemorrhage who received therapeutic oxytocin divided by the number of all women with postpartum haemorrhage
cThe number of women with eclampsia who received magnesium sulfate divided by the number of all women with eclampsia
dThe number of women having a caesarean section and receiving prophylactic antibiotics divided by the number of all women having caesarean sections
eThe number of women with severe systemic infections or sepsis who received antibiotics divided by the number of all women with severe systemic infections
or sepsis
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manifestation of severe morbidity related to pregnancy,
childbirth and puerperium.
Sixteen maternal deaths occurred in Kelantan during
the study period, seven of which were due to direct
causes; three, indirect causes; and six, fortuitous deaths.
Direct maternal deaths are due to obstetric complica-
tions, whereas indirect deaths are due to previously
existing diseases or from a disease that develops and is
aggravated during pregnancy. The 10 maternal deaths
were caused by haemorrhage (three cases), eclampsia
(one case), ectopic pregnancy (one case), amniotic fluid
embolism (one case), infection (two cases) and undeter-
mined (two cases). The WHO estimates that haemor-
rhage accounted for 27.1 % of maternal deaths;
hypertensive disorders, 14.0 %; and sepsis, 10.7 %. The
other deaths were due to abortion (7.9 %), embolism
(3.2 %) and all other direct causes of death (9.6 %)
worldwide [28].
Maternal near miss mortality ratio
In addition to prevalence, other indicators such as the
maternal near miss mortality ratio and mortality index
were used to describe the obstetric care. The maternal
near miss mortality ratio estimates the complexity of
care and refers to the ratio of maternal near miss cases
and maternal death. This ratio also represents the pro-
portion of maternal near miss cases that progressed to
maternal death; the higher the ratio, the better the qual-
ity of care that the women received [4]. During the study
period, two maternal deaths occurred and 47 cases of
maternal near miss were identified in the two tertiary
centres, revealing a maternal near miss mortality ratio of
23.5. Thus, for every 24 to 25 maternal near miss condi-
tions, one maternal death occurred. The occurrence of
at least four maternal near misses to every one maternal
death also confirms other reports in the literature that
justify the study of near miss cases [29].
Clearly, maternal near miss cases are more likely to
die in resource-poor settings. For example, using similar
WHO criteria [4], studies conducted in South Africa
(Nigeria, Tanzania and Ghana) and Pakistan observed
near miss to mortality ratios ranging from 1.5 to 2.5
[8, 17, 24, 30], while Brazil, India, Nepal and Iraq had
near miss to mortality ratios ranging from 3.3 to 8.6
[7, 10–13, 15, 16, 18–20]. The ratio reported in this
study is relatively high but is consistent with a study per-
formed in China (23.0) [14] in which a similar method of
data collection was applied. Higher ratios indicate a low
maternal mortality ratio and better quality of care [4]. An
overall increase in the ratio was observed in Brazilian
studies with data collected from tertiary maternity hospi-
tals from 2008 to 2012 [7, 10, 12, 16, 19, 20], except for a
study by Lotufo et al. [15] that was conducted with data
from a general intensive care unit. The increase in the
near miss to mortality ratio over the period reflects an im-
provement in obstetric care. Therefore, instead of a single
estimation, yearly estimations may facilitate monitoring
and improving the quality of care provided.
Mortality index
The mortality index is an indicator to represents an esti-
mate of performance. This index refers to the number of
maternal deaths divided by the number of women with
maternal near miss and maternal death and is expressed
as a percentage [4]. Our findings revealed a mortality
index of 4.1 %, which is comparable to the 4.2 % mortal-
ity index reported by Shen et al. (2013) in China. A high
index (>20 %) indicates low quality obstetric care for se-
vere cases, in which more women with severe conditions
die. In contrast, a low index (< 5 %) indicates better
quality of care, with fewer women with severe conditions
dying [4]. Thus, the health facilities in this study are per-
forming well regarding management of complex and se-
vere cases.
High mortality indexes ranging from 22.9 to 40.8 %
were reported in several studies in Africa, Latin America
and Pakistan [8, 17, 19, 20, 24, 30]. Of these studies, two
were the early retrospective studies in Brazil (2008 to
2009) [19, 20] and the highest index was reported in
Nigeria [24]. In contrast, other studies in Brazil, Iraq,
India and Nepal reported indexes between 10.4 and
18.1 % [7, 10–13, 16, 18].
Clinical disorders
Haemorrhagic and hypertensive disorders were the two
leading causes of severe maternal morbidity and mater-
nal near miss in our study. This finding is consistent
with other published studies in developing countries
[11, 18, 30]. These obstetric events, which correlate
with death, were also identified as the leading causes of
maternal death in Malaysia [2].
Haemorrhagic disorders, primarily postpartum haem-
orrhage, ectopic pregnancy and abruptio placenta, ac-
count for approximately 50, 8 and 6 % of the severe
maternal morbidity cases, respectively. A similar pattern
observed in the maternal near miss cases indicated the
potential progression of haemorrhagic complications to
near miss and death. The finding that postpartum haem-
orrhage contributes the largest proportion is in line with
the findings of other severe maternal morbidity and ma-
ternal near miss studies (36.1 to 48.5 %) [14, 18, 30].
Most of the cases of postpartum haemorrhage were due
to uterine atony, consistent with studies reported else-
where [15, 31, 32].
Ectopic pregnancy occurs in 1 to 2 % of all pregnan-
cies and is the primary cause of morbidity and mortality
in the first trimester of pregnancy [33]. The occurrence
of ectopic pregnancy was 3.2 % [34] of severe maternal
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morbidity cases and approximately 12 % [15, 24] of ma-
ternal near miss cases. In our study, the occurrence of
ectopic pregnancy was approximately 8 % in both condi-
tions. The prevention of ectopic pregnancy in severe ma-
ternal morbidity cases remains a challenge as no risk
factors have been identified that can predict severe
intra-abdominal bleeding [35].
Abruptio placenta, the single most important cause of
antepartum haemorrhage, complicates approximately 0.4
to 1 % of pregnancies [36], accounting for 7.1 % of se-
vere maternal morbidity cases and 6.4 % of maternal
near miss cases in our study, within the range reported
elsewhere [15, 24, 37].
Hypertensive disorders, specifically pre-eclampsia,
were the second highest cause of morbidity in our study.
In spite of the high proportion of pre-eclampsia cases,
the relatively low proportion of eclampsia cases may
suggest adequate prevention of seizures. The progression
to organ dysfunction occurred in seven cases (6.8 %) of
pre-eclampsia and in two cases (9.1 %) of eclampsia. Ap-
propriate and timely obstetrical care such as administra-
tion of magnesium sulphate and delivery of the placenta
is crucial for preventing of morbidity and mortality. Even
so, pre-eclampsia, which was thought to be a self-limited
entity, appears to cause real damage to cardiovascular
endothelial function [38]. Hypertensive disorders were also
strongly associated with an increased risk obstetric compli-
cations such as abruptio placenta, thrombocytopenia and
pulmonary oedema [39, 40].
Fluid overload imposed on severe pre-eclampsia pa-
tients may increase the risk of acute pulmonary
oedema. In our study, acute pulmonary edema was
prevalent in 2.5 % of severe maternal morbidity cases
and in 6.4 % of maternal near miss cases. A much
lower occurrence (0.9 %) of severe maternal morbidity
cases was observed [15]. Limited data were available
for comparison based on the WHO criteria. Among
the severe hypertensive disorders patients, maternal
near miss cases and maternal deaths were unsurpris-
ingly high (16.6 %) but only 0.8 % severe maternal morbid-
ity cases were observed [39].
The risk of uterine rupture is a concern for patients
with previous caesarean section delivery. A case-control
study on uterine rupture by the intended mode of deliv-
ery using the United Kingdom Obstetric Surveillance
System (UKOSS) reported that the risk of uterine rup-
ture with planned vaginal delivery in women with prior
caesarean section was low, at approximately one in 500
deliveries [41]. A subsequent UKOSS study showed that
the risk was more importantly associated with prosta-
glandin induction and oxytocin treatment during labour
[42]. Therefore, the use of prostaglandin and oxytocin
should be cautiously used during labour to improve pa-
tient safety.
Contributory factors
In our study, previous caesarean section was found in
22.5 and 36.2 % of women with severe maternal morbid-
ity and maternal near miss, respectively, contributing to
the vulnerable status of this population. This result is
consistent with findings from other studies regarding se-
vere maternal morbidity (9.5 to 34.9 %) [7, 8, 11, 14] and
maternal near miss (18.1 to 56.7 %) [8, 10, 11]. Previous
or current caesarean section is often associated with in-
creased likelihood of hysterectomy [43], consistent with
our study, which found that among the 19 women with
hysterectomy, 17 underwent caesarean section (14
emergency and 3 elective) and 12 (63.2 %) had previ-
ous caesarean section. This result suggests increased
anticipation towards postpartum haemorrhage and
peripartum hysterectomy for cases with previous and
current caesarean sections. However, the presence of
anaemia was unlikely to contribute to the morbid
condition.
Management of severe cases
Haemorrhagic complications had great potential for pro-
gression into near miss, which is consistent with the
high proportions of blood transfusion and hysterectomy
in this study. Blood transfusion of five or more units of
red blood cells indicates severe haemorrhage and a life-
saving measure, whereas fewer units may indicate mod-
erate anaemia to enhance postpartum recovery. A high
proportion of large blood transfusion (61.7 %) was ob-
served in our study. This result was much higher than
proportion of blood transfusion (24.0 to 46.3 %) ob-
served in maternal near miss cases in some studies
[14, 15, 21]. Therefore, continuous adequate supplies
and early access to blood products are crucial for suc-
cessful rescue.
For patient safety, peripartum hysterectomy due to ob-
stetric haemorrhage was commonly performed when
other treatment modalities failed. In the same studies, in
addition to receiving large blood transfusion, hysterec-
tomy was performed [14, 15, 21]. All women that con-
sented to hysterectomy (primarily for uterine atony,
abnormal placental invasion or uterine rupture) in our
study facilities survived. This finding highlights the need
for an available surgical team to perform hysterectomy
whenever required or an early referral to centres provid-
ing such services.
In our study, ICU admission with obstetric complica-
tions corresponded to 3.1 per 1000 live births. The most
frequent obstetric morbidities transferred to ICU oc-
curred following hysterectomy (17/19, 89.5 %) and
haemorrhage due to placental implantation disorders
(10/13, 76.9 %). The ICU transferals were for immediate
post-operative surveillance and for intensive treatment
purposes such as shock. The admission of obstetric cases
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to the ICU was very low, at 0.3 % (less than 0.5 %) and
the admission of maternal near miss cases to the ICU
was barely above the recommended standard, at 73.5 %
(70 %) [4]. Approximately 20 to 50 % of women with
maternal near miss failed to receive ICU care from
events such as postpartum haemorrhage, placental im-
plantation disorders and eclampsia, corroborating with
the substantial proportion (46.8 %) of women experien-
cing two and more organ dysfunctions. This result sug-
gests a shortage of ICU beds or the need to review the
number of readily available ICU beds for obstetric
patients.
Women presenting with obstetric complications may
require a higher level of care. Those women with organ
dysfunction would be more appropriately managed in
the ICU to provide optimum care and to minimize the
number of multiple organ failures [44]. Although an
evidence-based triage system to assist clinicians regard-
ing maternal utilization of intensive care services is lack-
ing, haemorrhagic and hypertensive disorders were the
two most common disorders in which admission into
the ICU was deemed necessary [45].
Organ dysfunction
Characterization of maternal near miss conditions accord-
ing to organ system dysfunction is unquestionably feasible
in tertiary hospitals in which procedures for monitoring
are routinely performed without resource constraints [46].
By occurrence, the coagulation/haematologic dysfunction
was the most common event followed by uterine and car-
diovascular dysfunctions in our study. These events were
manifested by large blood transfusion, hysterectomy and
severe hypoperfusion criteria.
Cases that developed complications on arrival or within
12 h of arrival must be separated from those cases that de-
veloped complications in the hospital setting because the
former would indicate failure in accessing tertiary centres
and/or referral systems. Approximately half of women
with severe maternal morbidity (46.3 %) and maternal
near miss (55.3 %) developed complications within 12 h of
admission, of which 68.3 and 61.5 % were referred cases,
which may partly indicate an issue of delay in the referral
system. Second, interestingly, the mortality index for in-
hospital patients was 5.0 % compared to 3.4 % for referred
cases. The higher mortality index suggests that the quality
of care provided to in-hospital patients needs to be further
reviewed concerning clinical management.
Essential interventions
The use of oxytocin for the prevention and treatment of
postpartum haemorrhage, of magnesium sulphate for
the treatment of eclampsia, of prophylactic antibiotics
for caesarean section and of parenteral antibiotics for
the treatment of sepsis was covered almost 100 %. The
coverage of recommended interventions below 95 %
should be interpreted as an opportunity to improve care
[4]. Good adherence to the measurable standards of the
WHO guidelines suggests good quality of care in these
facilities.
High coverage of essential interventions was observed
in various countries participating in the WHOMCS;
18 % of women with severe maternal outcomes (mater-
nal near miss and maternal death) did not receive the in-
dicated interventions [23]. In poor-resource settings, a
lack of information regarding organ dysfunction and an
inadequate assessment of severity may contribute to the
suboptimal implementation of essential interventions
and clinical management. However, in our study, the
process indicators of basic interventions seemed to be
widely practiced and did not provide additional informa-
tion regarding tertiary hospitals.
Coverage of essential interventions was suggested as
the first important step in analysing the issues related to
the quality of care. However, notably, application of
these single elements of care in the provision of a com-
prehensive care system may not be adequate [23, 28].
For an instance, in relation to the care for postpartum
haemorrhage, apart from the use of oxytocin for its pre-
vention and treatment, other aspects of care such as
shock management, an adequate donated blood supply
and prompt surgical interventions are essential. Simi-
larly, for the care of eclampsia, the role of magnesium
sulphate is fundamental but severe hypertension man-
agement, pre-delivery stabilization and airway restor-
ation are also vital. Although our study fared better with
respect to coverage of essential interventions, further re-
duction of maternal mortality can be achieved by ad-
dressing these deficiencies.
The relevance of the essential interventions in further re-
ducing maternal mortality has recently been questioned
[47]. For example, in the WHOMCS, first, the risk of death
did not increased [OR (95 % CI): 1.3 (0.81, 1.97], P = 0.330]
in women with severe maternal outcomes that missed the
opportunity to receive essential interventions compared to
women without missed opportunities. Second, paradoxical
performance regarding maternal mortality was observed.
Coverage of all the five essential interventions was low in
countries with low MMR and high in countries with high
MMR. Although the differences between countries with
low, moderate, high and very high MMR were not signifi-
cant for three of the essential interventions, the coverage
were significantly different for prophylactic antibiotics for
caesarean section and parenteral antibiotics for sepsis.
Thus, elements of care other than the essential interven-
tions play an important role in the survival of women with
morbid conditions [23].
According to the WHO process indicator, women pre-
sented at the hospital with obstructed labour or uterine
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rupture should undergo operations within three hours of
admission. Failure to do so reflects substandard care and
suggests an intra-hospital delay in the management of
obstructed labour [4]. In our study, the cases of ruptured
uterus occurred beyond the time limit. However, this
process indicator is limited to cases of obstructed labour
and uterine rupture presented at the hospital and not for
hospitalized patients, suggesting the need for an im-
proved indicator of ruptured uterus or new indicators
related to prolonged or obstructed labour.
End of pregnancy and pregnancy outcome
In our study, more than half of the pregnancies were ter-
minated via emergency caesarean section, indicating the
urgency of the obstetric conditions. Babies delivered to
mothers with severe maternal morbidity and maternal
near miss require neonatal ICU admission more fre-
quently, as similarly reported by Lotufo et al. [15]. Half
of the indications for admission to the neonatal ICU in
our study were linked to preterm birth. Stillbirths due to
severe maternal morbidity contributed to 5.1 % of all
stillbirths, while, abruptio placenta accounted for 77.8 %
of stillbirths in severe maternal morbidity cases. Among
cases with abruptio placenta, the perinatal mortality was
32.1 %. In addition to the severity of abruptio placenta,
foetal survival depends on the gestational age [36], and
most of the stillbirths occurred prematurely, between 25
and 35 weeks.
Recommendation
Notably, the causes of severe maternal morbidity and
maternal near miss were similar to the leading causes of
maternal death. This result is relevant for identifying in-
terventions that can be performed during antenatal care
and delivery to reduce maternal death. Auditing of these
cases demonstrated to be feasible despite the large num-
ber of cases [48]. In addition, the process of auditing
would lead to increased experience in tackling the deter-
minants of maternal morbidity [48] and understanding
the real demands at each level of health care [3].
Obstetric emergencies, namely, haemorrhagic and
hypertensive disorders should remain the priority topics
for training, although the stagnant progress in reducing
maternal mortality may not be attributed to the lack of
knowledge regarding its complications and management.
Of note, the possible reasons for this lack of progress
may lie in the organization, delivery and utilization of
services, as explained by the disproportionately small
number of maternal deaths (2/10, 20.0 %) occurring in
tertiary centres compared to lower level health facilities,
with most of the complications having developed during
the course of labour and delivery. Implementing a sur-
veillance strategy for women with severe maternal mor-
bidity allows early identification of complications and
better preparedness for acute morbidities. This imple-
mentation includes ongoing evidence-based guidelines,
audits, obstetric table top simulations and awareness of
red flags among junior health care providers or lower
level facilities to minimize delays in management and
referrals.
Cases of ruptured uterus occurring in hospitalized
women are an important indication of the seriousness of
substandard care. The current process indicator has out-
lined that women presented at the hospital with
obstructed labour or uterine rupture should undergo op-
eration within three hours of admission. Modification
and improvement of this indicator is highly required.
This study suggests for the monitoring to begin from the
time these diagnoses were made for hospitalized patients
but with shorter time limit.
Of 10 maternal deaths, two deaths occurred in tertiary
centres and four deaths occurred in hospitals with and
without obstetrics and gynaecology specialists (the
remaining four women were brought in dead). This re-
sult implies that, apart from patient factors, the occur-
rence of severe maternal morbidity and maternal near
miss, similar to maternal deaths, may be influenced by
the health care level. Research involving different levels
of health facilities should be repeated to objectively iden-
tify issues related to pregnancy complications upon
which appropriate interventions could be adopted. Apart
from allowing comparisons between health facilities, a
single health facility could monitor its progress over
time.
Limitations
The findings of this study should not be regarded as rep-
resentative of Kelantan but indicative of a large hospital-
based tertiary centre study. The maternal outcomes in
community-based birthing centres and district level hos-
pitals were not assessed. Utilization of the WHO mater-
nal near miss criteria seems to be limited in smaller
health facilities. The laboratory-based (for example, pH,
PaO2 and lactate) and management-based markers (for
example, vasoactive drug management and hysterec-
tomy) are less likely to be applicable in these health fa-
cilities. Therefore, we support severe maternal morbidity
as the initial classification in the continuum that begins
with any occurrence of complications of pregnancy, de-
livery and puerperium until death. It is proposed that
this pragmatic criteria approach related to severe mater-
nal morbidity be applied at poor-resource health facil-
ities and the strict near miss criteria approach related to
organ dysfunctions be applied for quantitative assess-
ments and international comparisons. Thus, the strict
near miss criteria should be incorporated as much as
possible [49]. These approaches should complement
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each other to obtain information to improve maternal
health.
Conclusion
The reduced maternal morbidities corresponded with
the high coverage of essential interventions in these ter-
tiary centres. Comprehensive emergency care and inten-
sive care and overall improvements in the quality care
for maternal health need to be further examined to
achieve substantial reductions in maternal death.
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